Joost R.
- Country
- The Netherlands
- Department
- #3301: Neurology
Research Overview
- Evaluation of Filgotinib on Quality of Life, Disease Activity, and Safety in Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
- Evaluation of Intravenous Human Normal Immunoglobulin and Prednisone Versus Prednisone Alone in Newly Diagnosed Idiopathic Inflammatory Myopathy
- Evaluation of Rapcabtagene Autoleucel Versus Standard Treatment in Severe Refractory Idiopathic Inflammatory Myopathies: A Phase 2 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 3 of 55 partner sites.
Specializations
Inflammatory Myopathies
The investigator specializes in treating idiopathic inflammatory myopathies (IIM), with particular focus on both newly diagnosed and refractory cases. Their research encompasses various therapeutic approaches for this rare autoimmune condition.
- Standard and Novel Treatments
- Refractory Disease Management
- Early Intervention Strategies
Their expertise extends to evaluating both conventional and innovative therapeutic options for IIM patients.
Autoimmune Disorders
The investigator has developed significant expertise in treating complex immune-mediated inflammatory diseases, particularly focusing on Behçet's disease and IgG4-related disease.
- Rare Disease Management
- Inflammatory Disease Therapy
- Treatment-Resistant Conditions
Their work addresses the challenges of treating refractory manifestations of these rare conditions.
Treatment Innovation
The investigator explores advanced therapeutic approaches including JAK inhibition and immunoglobulin therapy for inflammatory conditions. Their research evaluates treatment efficacy in improving quality of life and disease activity.
- Novel Therapeutic Approaches
- Quality of Life Assessment
- Safety Evaluation
Their work encompasses both established and emerging treatment modalities for complex inflammatory disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.